TYRA: Tyra Biosciences, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-21 | New 13G stake | BIOTECHNOLOGY VALUE FUND L P | 6.10% | SEC | |
| 2026-09-17 | 13D amendment | RA Capital Management, L.P. | 19.90% | SEC | |
| 2026-09-17 | New 13G stake | Paradigm BioCapital Advisors LP | 5.80% | SEC | |
| 2026-08-14 | 13G amendment | Nextech VI Oncology SCSp | 6.00% | SEC | |
| 2026-08-14 | Fell below 5% | Farallon Capital Management, L.L.C. | 0.00% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.